<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Friedrich M</submitter><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NIAMS NIH HHS</funding><funding>Kennedy Trust</funding><funding>Wellcome Trust</funding><pagination>1970-1981</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8604730</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(11)</volume><pubmed_abstract>Current inflammatory bowel disease (IBD) therapies are ineffective in a high proportion of patients. Combining bulk and single-cell transcriptomics, quantitative histopathology and in situ localization across three cohorts of patients with IBD (total n = 376), we identify coexpressed gene modules within the heterogeneous tissular inflammatory response in IBD that map to distinct histopathological and cellular features (pathotypes). One of these pathotypes is defined by high neutrophil infiltration, activation of fibroblasts and vascular remodeling at sites of deep ulceration. Activated fibroblasts in the ulcer bed display neutrophil-chemoattractant properties that are IL-1R, but not TNF, dependent. Pathotype-associated neutrophil and fibroblast signatures are increased in nonresponders to </pubmed_abstract><journal>Nature medicine</journal><pubmed_title>IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.</pubmed_title><pmcid>PMC8604730</pmcid><funding_grant_id>K08 AR077037</funding_grant_id><funding_grant_id>KENN161701</funding_grant_id><funding_grant_id>095688/Z/11/Z</funding_grant_id><funding_grant_id>MR/N02690X/1</funding_grant_id><funding_grant_id>212240/Z/18/Z</funding_grant_id><funding_grant_id>KENN192004</funding_grant_id><funding_grant_id>KENN202101</funding_grant_id><funding_grant_id>KENN161703</funding_grant_id><funding_grant_id>ACF-2017-13-008</funding_grant_id><funding_grant_id>MR/V001949/1</funding_grant_id><pubmed_authors>Korsunsky I</pubmed_authors><pubmed_authors>Frei AP</pubmed_authors><pubmed_authors>Uhlig HH</pubmed_authors><pubmed_authors>Sathananthan D</pubmed_authors><pubmed_authors>Sharpe H</pubmed_authors><pubmed_authors>Mann EH</pubmed_authors><pubmed_authors>Rue-Albrecht K</pubmed_authors><pubmed_authors>Watts GFM</pubmed_authors><pubmed_authors>Raychaudhuri S</pubmed_authors><pubmed_authors>Oxford IBD Cohort Investigators</pubmed_authors><pubmed_authors>Lassen KG</pubmed_authors><pubmed_authors>Thomas L</pubmed_authors><pubmed_authors>Ravindran R</pubmed_authors><pubmed_authors>Powrie FM</pubmed_authors><pubmed_authors>Thomas T</pubmed_authors><pubmed_authors>Barone F</pubmed_authors><pubmed_authors>Easton A</pubmed_authors><pubmed_authors>Tandon R</pubmed_authors><pubmed_authors>Wei K</pubmed_authors><pubmed_authors>Jackson MA</pubmed_authors><pubmed_authors>Attar M</pubmed_authors><pubmed_authors>Peres RS</pubmed_authors><pubmed_authors>Buckley CD</pubmed_authors><pubmed_authors>Bullers SJ</pubmed_authors><pubmed_authors>Travis SP</pubmed_authors><pubmed_authors>McCuaig S</pubmed_authors><pubmed_authors>Sansom SN</pubmed_authors><pubmed_authors>Christoforidou Z</pubmed_authors><pubmed_authors>Friedrich M</pubmed_authors><pubmed_authors>Geremia A</pubmed_authors><pubmed_authors>Coles M</pubmed_authors><pubmed_authors>Collantes E</pubmed_authors><pubmed_authors>Pohin M</pubmed_authors><pubmed_authors>Roche Fibroblast Network Consortium</pubmed_authors><pubmed_authors>Brenner M</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.</name><description>Current inflammatory bowel disease (IBD) therapies are ineffective in a high proportion of patients. Combining bulk and single-cell transcriptomics, quantitative histopathology and in situ localization across three cohorts of patients with IBD (total n = 376), we identify coexpressed gene modules within the heterogeneous tissular inflammatory response in IBD that map to distinct histopathological and cellular features (pathotypes). One of these pathotypes is defined by high neutrophil infiltration, activation of fibroblasts and vascular remodeling at sites of deep ulceration. Activated fibroblasts in the ulcer bed display neutrophil-chemoattractant properties that are IL-1R, but not TNF, dependent. Pathotype-associated neutrophil and fibroblast signatures are increased in nonresponders to </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-05-08T14:24:06.45Z</modification><creation>2022-02-11T13:29:12.397Z</creation></dates><accession>S-EPMC8604730</accession><cross_references><pubmed>34675383</pubmed><doi>10.1038/s41591-021-01520-5</doi></cross_references></HashMap>